Found: 26
Select item for more details and to access through your institution.
Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 711, doi. 10.1007/s00280-014-2397-9
- By:
- Publication type:
- Article
The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 869, doi. 10.1007/s00280-014-2415-y
- By:
- Publication type:
- Article
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 729, doi. 10.1007/s00280-014-2399-7
- By:
- Publication type:
- Article
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 839, doi. 10.1007/s00280-014-2414-z
- By:
- Publication type:
- Article
Phase II clinical trial of PM00104 (Zalypsis((R))) in urothelial carcinoma patients progressing after first-line platinum-based regimen.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 799, doi. 10.1007/s00280-014-2407-y
- By:
- Publication type:
- Article
Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 807, doi. 10.1007/s00280-014-2408-x
- By:
- Publication type:
- Article
Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 695, doi. 10.1007/s00280-014-2391-2
- By:
- Publication type:
- Article
BRCA- 1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 771, doi. 10.1007/s00280-014-2404-1
- By:
- Publication type:
- Article
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 819, doi. 10.1007/s00280-014-2411-2
- By:
- Publication type:
- Article
Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 685, doi. 10.1007/s00280-014-2387-y
- By:
- Publication type:
- Article
Population pharmacokinetics of afatinib, an irreversible ErbB family blocker, in patients with various solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 759, doi. 10.1007/s00280-014-2403-2
- By:
- Publication type:
- Article
A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 665, doi. 10.1007/s00280-013-2371-y
- By:
- Publication type:
- Article
Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 779, doi. 10.1007/s00280-014-2405-0
- By:
- Publication type:
- Article
The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 847, doi. 10.1007/s00280-014-2416-x
- By:
- Publication type:
- Article
Phase II clinical trial of PM00104 (Zalypsis) in urothelial carcinoma patients progressing after first-line platinum-based regimen.
- Published in:
- 2014
- By:
- Publication type:
- Report
Pharmacokinetics of doxorubicin in pregnant women.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 789, doi. 10.1007/s00280-014-2406-z
- By:
- Publication type:
- Article
Therapy resistance mechanisms in Ewing's sarcoma family tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 657, doi. 10.1007/s00280-014-2392-1
- By:
- Publication type:
- Article
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 827, doi. 10.1007/s00280-014-2412-1
- By:
- Publication type:
- Article
Phase 1 study of pazopanib alone or combined with lapatinib in Japanese patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 673, doi. 10.1007/s00280-014-2374-3
- By:
- Publication type:
- Article
Clinical pharmacokinetics of Icotinib, an anti-cancer drug: evaluation of dose proportionality, food effect, and tolerability in healthy subjects.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 721, doi. 10.1007/s00280-014-2398-8
- By:
- Publication type:
- Article
Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 703, doi. 10.1007/s00280-014-2394-z
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure-response analyses of trastuzumab in patients with advanced gastric or gastroesophageal junction cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 737, doi. 10.1007/s00280-014-2400-5
- By:
- Publication type:
- Article
Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 4, p. 749, doi. 10.1007/s00280-014-2401-4
- By:
- Publication type:
- Article